TEL/AML1 positivity in childhood ALL: Average or better prognosis?

Leukemia

Volumn 13, Issue 1, 1999, Pages 22-24

  Zuna, J ^a   Hrusak O ^b   Kalinova M ^b   Muzikova K ^b   Stary J ^b   Trka, J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

Childhood acute lymphoblastic leukaemia; Minimal residual disease; Prognosis relapse; TEL AML1 fusion gene

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CZECH REPUBLIC; FUSION GENE; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RELAPSE;

EID: 0345628621     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401256     Document Type: Article

References (13)

1. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GCF, Pui CH, Grosveld G. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985-1989.
2. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz: J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996; 88: 4252-4258.
3. Rubnitz JE, Behm FG, Pui CH, Evans WE, Relling MV, Raimondi SC, Harrison PL, Sandlund JT, Ribeiro RC, Grosveld G, Downing JR. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia 1997; 11: 1201-1206.
4. Rubnitz JE, Downing JR, Pui CH, Shurtleff SA, Raimondi SC, Evans WE, Head DR, Crist WM, Rivera GK, Hancock ML, Boyett JM, Buijs A, Grosveld G, Behm FG. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol 1997; 15: 1150-1157.
5. Harbott J, Viehman S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933-4937.
6. Seeger K, Adams HP, Buchwald D, Beyerman B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G for the Berlin-Frankfurt-Munster Study Group. TEL/AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. Blood 1998; 9: 1716-1722.
7. Satake N, Kobayashi H, Tsunematsu Y, Kawasaki H, Horikoshi Y, Koizumi S, Kaneko Y. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21). Br J Haematol 1997; 97: 607-611.
8. Cayuela JM, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 1996; 88: 302-308.
9. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 1463-1470.
10. Hrušák O, Trka J, Zuna J, Housková J, Bartůňkova J, Starý J for the Pediatric Hematology Working Group in the Czech Republic. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. Leukemia 1998; 12: 1064-1070.
11. Trka J, Zuna J, Hrušák O, Kalinová M, Mužíková K, Lauschman H, Starý J for Paediatric Haematology Working Group in the Czech Republic. Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Leukemia 1998; 12: 996-998.
12. Goulden NJ, Knechtli CJC, Garland RJ, Langlands K, Hancock JP, Potter MN, Steward CG, Oakhill A. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia. Br J Haematol 1998; 100: 235-244.
13. Rubnitz JE, Pui CH, Downing JR. The role of TEL fusion genes in pediatric leukemias. Leukemia 1999 (in press).